Hepatic Insulin Clearance Is Closely Related to Metabolic Syndrome Components
Open Access
- 15 October 2013
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 36 (11) , 3779-3785
Abstract
OBJECTIVE Insulin clearance is decreased in type 2 diabetes mellitus (T2DM) for unknown reasons. Subjects with metabolic syndrome are hyperinsulinemic and have an increased risk of T2DM. We aimed to investigate the relationship between hepatic insulin clearance (HIC) and different components of metabolic syndrome and tested the hypothesis that HIC may predict the risk of metabolic syndrome. RESEARCH DESIGN AND METHODS Individuals without diabetes from the Metabolic Syndrome Berlin Brandenburg (MeSyBePo) study (800 subjects with the baseline examination and 189 subjects from the MeSyBePo recall study) underwent an oral glucose tolerance test (OGTT) with assessment of insulin secretion (insulin secretion rate [ISR]) and insulin sensitivity. Two indices of HIC were calculated. RESULTS Both HIC indices showed lower values in subjects with metabolic syndrome (P < 0.001) at baseline. HIC indices correlate inversely with waist circumference, diastolic blood pressure, fasting glucose, triglycerides, and OGTT-derived insulin secretion index. During a mean follow-up of 5.1 ± 0.9 years, 47 individuals developed metabolic syndrome and 33 subjects progressed to impaired glucose metabolism. Both indices of HIC showed a trend of an association with increased risk of metabolic syndrome (HICC-peptide odds ratio 1.13 [95% CI 0.97–1.31], P = 0.12, and HICISR 1.38 [0.88–2.17], P = 0.16) and impaired glucose metabolism (HICC-peptide 1.12 [0.92–1.36], P = 0.26, and HICISR 1.31 [0.74–2.33] P = 0.36), although point estimates reached no statistical significance. CONCLUSIONS HIC was associated with different components of metabolic syndrome and markers of insulin secretion and insulin sensitivity. Decreased HIC may represent a novel pathophysiological mechanism of the metabolic syndrome, which may be used additionally for early identification of high-risk subjects.Keywords
This publication has 40 references indexed in Scilit:
- Fasting insulin reflects heterogeneous physiological processes: role of insulin clearanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and WomenDiabetes, 2011
- Caloric Restriction Reverses Hepatic Insulin Resistance and Steatosis in Rats with Low Aerobic CapacityEndocrinology, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Insulin Resistance and HyperinsulinemiaDiabetes Care, 2008
- Effect of liver fat on insulin clearanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Association of the -514C→T polymorphism in the Hepatic Lipase Gene (LIPC) Promoter with Elevated Fasting Insulin Concentrations, but not Insulin Resistance, in Non-diabetic GermansHormone and Metabolic Research, 2004
- Flexible regression models with cubic splinesStatistics in Medicine, 1989
- Quantitative study of insulin secretion and clearance in normal and obese subjects.Journal of Clinical Investigation, 1988